AstraZeneca Cuts Discounted Drug Pricing Deal With the White House. The Stock Is Rising.

1. AstraZeneca agrees to drug pricing deal with the White House. 2. Commitment to Medicaid at 'most favored nation prices' announced. 3. Plans for $50 billion investment in U.S. R&D within five years. 4. New plant in Virginia to create 3,600 jobs. 5. Stock rose 1.6% in after-hours trading following the announcement.